VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,013,262 | -46.2% | 3,475,292 | -18.0% | 0.00% | -100.0% |
| Q2 2023 | $27,924,703 | -0.4% | 4,237,436 | +2.6% | 0.00% | 0.0% |
| Q1 2023 | $28,029,894 | -5.0% | 4,128,114 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $29,502,107 | -23.3% | 3,992,166 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $38,478,000 | -8.0% | 3,894,554 | +1.5% | 0.00% | 0.0% |
| Q2 2022 | $41,832,000 | -2.0% | 3,837,732 | +1.6% | 0.00% | 0.0% |
| Q1 2022 | $42,706,000 | -29.8% | 3,775,841 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $60,826,000 | -11.0% | 3,876,684 | -2.7% | 0.00% | -50.0% |
| Q3 2021 | $68,321,000 | -22.5% | 3,986,128 | -2.7% | 0.00% | 0.0% |
| Q2 2021 | $88,107,000 | +45.4% | 4,096,078 | +1.5% | 0.00% | 0.0% |
| Q1 2021 | $60,612,000 | +16.5% | 4,035,484 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $52,023,000 | +37.0% | 3,959,080 | +0.7% | 0.00% | +100.0% |
| Q3 2020 | $37,973,000 | -22.9% | 3,930,941 | -8.7% | 0.00% | -50.0% |
| Q2 2020 | $49,232,000 | +7.3% | 4,303,657 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $45,883,000 | -37.3% | 4,428,915 | -0.7% | 0.00% | 0.0% |
| Q4 2019 | $73,202,000 | +27.9% | 4,460,783 | +3.5% | 0.00% | 0.0% |
| Q3 2019 | $57,220,000 | +12.5% | 4,308,706 | +19.3% | 0.00% | 0.0% |
| Q2 2019 | $50,870,000 | -30.7% | 3,610,341 | -9.6% | 0.00% | -33.3% |
| Q1 2019 | $73,447,000 | -32.5% | 3,991,732 | -4.1% | 0.00% | -40.0% |
| Q4 2018 | $108,819,000 | +19.4% | 4,164,512 | +4.9% | 0.01% | +25.0% |
| Q3 2018 | $91,111,000 | +43.2% | 3,969,954 | +18.8% | 0.00% | +33.3% |
| Q2 2018 | $63,645,000 | +20.3% | 3,340,868 | +6.4% | 0.00% | +50.0% |
| Q1 2018 | $52,884,000 | +22.9% | 3,138,560 | +10.9% | 0.00% | 0.0% |
| Q4 2017 | $43,026,000 | -13.4% | 2,830,627 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $49,662,000 | +13.6% | 2,774,367 | +3.5% | 0.00% | 0.0% |
| Q2 2017 | $43,698,000 | +25.1% | 2,680,895 | +7.5% | 0.00% | 0.0% |
| Q1 2017 | $34,920,000 | +11.0% | 2,494,347 | +26.4% | 0.00% | 0.0% |
| Q4 2016 | $31,464,000 | +13.5% | 1,972,678 | +18.4% | 0.00% | 0.0% |
| Q3 2016 | $27,713,000 | +53.9% | 1,665,414 | +3.5% | 0.00% | +100.0% |
| Q2 2016 | $18,003,000 | +34.9% | 1,608,935 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $13,346,000 | -3.5% | 1,596,278 | +7.5% | 0.00% | 0.0% |
| Q4 2015 | $13,825,000 | -16.1% | 1,484,928 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $16,482,000 | -6.0% | 1,461,131 | +5.7% | 0.00% | 0.0% |
| Q2 2015 | $17,535,000 | +51.0% | 1,381,756 | +10.7% | 0.00% | 0.0% |
| Q1 2015 | $11,612,000 | -31.3% | 1,248,686 | +5.8% | 0.00% | 0.0% |
| Q4 2014 | $16,905,000 | +54.7% | 1,180,527 | +12.1% | 0.00% | 0.0% |
| Q3 2014 | $10,931,000 | -33.6% | 1,053,086 | +3.6% | 0.00% | 0.0% |
| Q2 2014 | $16,450,000 | +1.0% | 1,016,733 | +1.4% | 0.00% | 0.0% |
| Q1 2014 | $16,288,000 | +39.1% | 1,002,342 | +6.2% | 0.00% | 0.0% |
| Q4 2013 | $11,713,000 | +18.4% | 943,899 | +4.7% | 0.00% | 0.0% |
| Q3 2013 | $9,890,000 | +56.1% | 901,562 | +15.0% | 0.00% | 0.0% |
| Q2 2013 | $6,337,000 | – | 784,271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |